Tofacitinib
Targeted Therapies
Common brand names
- Xeljanz
Approved use in
- Cutaneous T-Cell Lymphoma
- T-Cell Prolymphocytic Leukemia
Information about use in Blood Cancer
Information about use in Cutaneous T-Cell Lymphoma
Information about use in T-Cell Prolymphocytic Leukemia